A novel persulfide detection method reveals protein persulfide and polysulfide-reducing functions of thioredoxin and glutathione systems by Dóka, É. et al.
R E S EARCH ART I C L EB IOCHEM ISTRY1Department of Molecular Immunology and Toxicology, National Institute of Oncology,
Ráth György utca 7-9, Budapest 1122, Hungary. 2Division of Biochemistry, Department of
Medical Biochemistry and Biophysics, Karolinska Institutet, SE-171 77 Stockholm, Sweden.
3Department of Microbiology and Immunology, Montana State University, Cooley Hall,
PO Box 173520, Bozeman, MT 59717, USA. 4Division of Redox Regulation, German
Cancer Research Center (DKFZ), DKFZ-ZMBH Alliance, Im Neuenheimer Feld 280, 69120
Heidelberg, Germany.
*Corresponding author. E-mail: peter.nagy@oncol.hu
Dóka et al. Sci. Adv. 2016; 2 : e1500968 22 January 20162016 © The Authors, some rights reserved;
exclusive licensee American Association for
the Advancement of Science. Distributed
under a Creative Commons Attribution
NonCommercial License 4.0 (CC BY-NC).
10.1126/sciadv.1500968A novel persulfide detection method reveals
protein persulfide- and polysulfide-reducing
functions of thioredoxin and glutathione systems
Éva Dóka,1 Irina Pader,2 Adrienn Bíró,1 Katarina Johansson,2 Qing Cheng,2 Krisztina Ballagó,1 Justin R. Prigge,3
Daniel Pastor-Flores,4 Tobias P. Dick,4 Edward E. Schmidt,3 Elias S. J. Arnér,2 Péter Nagy1*http://advances.sc
D
ow
nloaded from
 Hydrogen sulfide signaling involves persulfide formation at specific protein Cys residues. However, overcoming current
methodological challenges in persulfide detection and elucidation of Cys regeneration mechanisms from persulfides
are prerequisites for constructing a bona fide signaling model. We here establish a novel, highly specific protein per-
sulfide detection protocol, ProPerDP, with which we quantify 1.52 ± 0.6 and 11.6 ± 6.9 mg/mg protein steady-state
protein persulfide concentrations in human embryonic kidney 293 (HEK293) cells and mouse liver, respectively. Upon
treatment with polysulfides, HEK293 and A549 cells exhibited increased protein persulfidation. Deletion of the sulfide-
producing cystathionine-g-lyase or cystathionine-b-synthase enzymes in yeast diminished protein persulfide levels,
thereby corroborating their involvement in protein persulfidation processes. We here establish that thioredoxin
(Trx) and glutathione (GSH) systems can independently catalyze reductions of inorganic polysulfides and protein per-
sulfides. Increased endogenous persulfide levels and protein persulfidation following polysulfide treatment in thio-
redoxin reductase-1 (TrxR1) or thioredoxin-related protein of 14 kDa (TRP14) knockdown HEK293 cells indicated
that these enzymes constitute a potent regeneration system of Cys residues from persulfides in a cellular context.
Furthermore, TrxR1-deficient cells were less viable upon treatment with toxic amounts of polysulfides compared to
control cells. Emphasizing the dominant role of cytosolic disulfide reduction systems in maintaining sulfane sulfur
homeostasis in vivo, protein persulfide levels were markedly elevated in mouse livers where hepatocytes lack both
TrxR1 and glutathione reductase (TR/GR-null). The different persulfide patterns observed in wild-type, GR-null, and
TR/GR-null livers suggest distinct roles for the Trx and GSH systems in regulating subsets of protein persulfides and
thereby fine-tuning sulfide signaling pathways. ien o
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Since the neuromodulator function of hydrogen sulfide (H2S) was dis-
covered about 20 years ago (1), extensive research has revealed master
regulator properties of H2S in a wide array of physiological processes
in almost all forms of life (2). In addition to being vital for normal human
physiology, H2S also plays central roles in many pathophysiological
events, substantiating sulfide-mediated signaling as a drug target (3, 4).
However, the understanding of the molecular mechanisms for H2S sig-
naling remains very limited (5). Enzyme and protein regulation via per-
sulfidation, that is, formation of persulfide (-SSH) moieties (a process also
known as protein S-sulfhydration), at regulatory cysteine (Cys) residues
is widely suggested as a major pathway (5, 6). Furthermore, sulfane sulfur
species (a collective name for compounds containing forms of sulfide
with an oxidation state of 0) are now recognized as mediators in redox
biology (7, 8) and nitric oxide signaling (9–12). Thus, increasing attention
in the field of redox signaling and sulfur biology has been diverted to
the biological roles of inorganic polysulfides (HSx
−) (13) and protein per-
sulfides (7, 14).
Despite a rapid evolution of fluorescent probes (15) and several
protein persulfide detection methods (16), there remains a very limitedunderstanding of the role of sulfane sulfur species in signaling pathways
and cellular redox homeostasis (17). For example, recently reported
relatively high cellular persulfide levels of up to 0.1 mM (7) were argued
to be in contrast with the notion of a highly reducing environment in the
cytosol that would counteract their formation (18), thus highlighting the
need of optimized and more specific persulfide detection methods. In
this context, it should also be noted that although persulfide formation
pathways have been rather extensively studied, the reducing mechanisms
that can regenerate native forms of Cys residues from persulfide species
remain largely elusive. Two recent reports have suggested the involvement
of thioredoxin (Trx) in metabolism of Cys persulfides (19, 20), but there
remains a lack of thorough mechanistic studies of such activities.
Here, we report the development and validation of a novel, easy-
to-use, and highly specific Protein Persulfide Detection Protocol
(ProPerDP), which can be used with intact cells and tissue samples.
We report the capacities of thioredoxin reductase-1 (TrxR1), Trx1,
and the alternative TrxR1-dependent redox active thioredoxin-related
protein of 14 kDa (TRP14) (21) to reduce polysulfides and protein
persulfide species and, utilizing ProPerDP, we demonstrate their im-
pacts on cellular protein persulfide levels. Apart from its recently rec-
ognized nitrosothiol- and cystine-reducing properties (22), our results
reveal that TRP14 is highly efficient in catalyzing protein persulfide and
HSx
− reduction. In addition, our results indicate that cells with a com-
promised Trx system exhibit decreased viability in the presence of toxic
amounts of inorganic polysulfides. Furthermore, we show that the glutar-
edoxin (Grx)/glutathione reductase (GR)/glutathione (GSH) machinery
can also catalytically reduce polysulfides and protein persulfides. Final-
ly, using ProPerDP on mouse liver samples lacking GR and/or TrxR11 of 14
R E S EARCH ART I C L Ein hepatocytes, we demonstrate the physiological significance of the
Trx and GSH systems to maintain sulfane sulfur homeostasis and sug-
gest their involvement in sulfide signaling.http://advances.sciencem
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 RESULTS
ProPerDP: A novel protein persulfide detection protocol
We here developed an easy, convenient, and reliable protein persulfide
detection protocol (ProPerDP), which we found to yield high specificity
(Fig. 1). In the initial step, protein Cys thiol (-SH) and persulfide (-SSH)
functional groups are alkylated using the biotin-labeled alkylating agent
EZ-Link Iodoacetyl-PEG2-Biotin (IAB) (Fig. 1, Sample 1) and can there-
after be pulled down from a protein mixture using streptavidin-coated
magnetic beads. Other oxidized Cys derivatives, such as disulfides, are
not alkylated under the conditions of ProPerDP and remain in the super-
natant (Fig. 1, Sample 2). Cys sulfenic acids (-SOH) or nitrosothiols (-SNO)
may become alkylated to some extent, but such reactions would generate
thioethers (-SR) just as with the free thiols and hence will not appear
as false positives in the final persulfide fraction (Sample 3). Derivatized
persulfides are separated from the original thiol groups in a reduction
step, where the thioethers (the thiol alkylation products) will remain
bound to the beads. However, the dialkyl disulfides derived from the
protein persulfides that were present in the original sample are selec-
tively cleaved off and can thus be quantified and subsequently visua-
lized on SDS–polyacrylamide gel electrophoresis (SDS-PAGE) (Fig. 1,
Sample 3). The thioether-containing proteins can also be detected by
SDS-PAGE upon their release from the beads by boiling in SDS-
containing sample buffer (Fig. 1, Sample 4).
Persulfide formation on human serum albumin
Human serum albumin (HSA) contains a single, freely accessible Cys
residue (Cys34) that can provide a site of protein persulfidation and wasDóka et al. Sci. Adv. 2016; 2 : e1500968 22 January 2016used as a model protein to validate the ProPerDP method. HSA per-
sulfide (HSA-SSH) was generated by reacting HSA with HSx
−. HSA-
SSH formation was confirmed by our previously reported indirect
measurement of protein-associated sulfane sulfur in concentrated solu-
tions of purified protein samples (23). This protocol is based on the
quantification of sulfide that is liberated upon reduction of desalted
protein persulfide samples by a modified monobromobimane method
(24). 10.2 ± 1.4 mM H2S ( mean ± SD from n = 5 experiments) was
liberated from 10 mMpurified, polysulfide-treated HSA, suggesting that
most of the free Cys34 can be persulfidated/polysulfidated by excess
HSx
−. With these HSA-SSH samples, we validated that ProPerDP in-
deed detects protein persulfides in a specific manner, with no background
signal seen if the persulfides were reduced before alkylation {S3 lanes
in the ±TCEP [tris(2-carboxyethyl)phosphine] samples in Fig. 2A}. A
decline in persulfide content was observed upon incubation of HSA-SSH
in the presence of added sulfide before the alkylation step in a dose-dependent
manner (Fig. 2A′ and fig. S1), confirming our previous observation that
persulfidation is an equilibrium process that can be shifted by the addi-
tion of either product or reactant species (25). However, depending on
the nature of the persulfidated Cys residues, such equilibrium (reac-
tion 1) can be largely shifted either to the left, as is the case with phos-
phatase and tensin homolog (PTEN) (23), or to the right, as with TNB
(2-nitro-5-thiobenzoic acid) that was derived from DTNB [5,5′-dithiobis-
(2-nitrobenzoic acid)] (25).
RSSH þ H2S ⇌ RSH þ HSSH ð1Þ
Using Coomassie staining andWestern blot analyses, ProPerDP also
allowed visualization of HSA-SSH formation in HSx
−-treated plasma
samples in a concentration-dependent manner (Fig. 2, B and C). Endog-
enous HSA-SSH was not detectable, and in contrast to previous sugges-
tions (26, 27), sulfide treatment of plasma samples could not generate
substantial amounts of HSA-SSH in our hands (Fig. 2C′). AlthoughHSA o
n
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rg/Fig. 1. Protein Persulfide Detection Protocol. Thiol and persulfide functional groups are alkylated by IAB to form the corresponding thioether and
dialkyl disulfide derivatives, respectively (-R denotes the electrophile moiety of the alkylating agent). Oxidized Cys residues of proteins in the original
sample (Sample 1) will not be derivatized by IAB. Affinity purification of alkylated proteins is achieved by pulldown with streptavidin-coated magnetic
beads, leaving proteins only containing oxidized Cys residues in the supernatant (Sample 2). Resuspension of purified beads in a reducing buffer selectively
cleaves the original persulfides off as thiols, which can be analyzed after separation with recovery from the beads, thus allowing the determination of
protein persulfides (Sample 3). Note that some sulfenic acid (-SOH) or nitrosothiol (-SNO) derivatives might become alkylated in Sample 1, but these
reactions give thioethers such as free thiols and hence do not appear as false positives in Sample 3. Native Cys residues with free thiols in the original
sample will not be released from the beads by reduction but can be recovered by boiling of the beads in SDS (Sample 4). The diamond symbol (◊)
denotes the biotin tag, and the pictogram in the inset refers to the biotin-streptavidin binding interaction. The order and nomenclature of the samples are
maintained for all gels and blots in this study, thereby referred to as S1 to S4, respectively.2 of 14
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 persulfidation could indeed be detected at very high sulfide concentra-
tions, this was most likely induced by an inevitable HSx
− contamination
(or formation of polysulfides during incubation) in the sulfide stock
solutions, as shown previously for analyses of the active-site residues
of PTEN (23).
Reduction of HSx
− by the Trx system
Persulfidation is inhibitory for most thiol enzyme functions (5), but
the effect of selenopersulfide (-SeSH) formation, to our knowledge,
has not been tested for any functional selenocysteine (Sec)–containing
enzyme. The Trx-reducing activities of mammalian TrxRs depend on a
conserved solvent-exposed and highly reactive C-terminal Sec residue
(28, 29). Therefore, we investigated how HSx
− exposure affects the ac-
tivity of TrxR1. Instead of enzyme inhibition, we found that in the
presence of its natural electron donor NADPH (reduced form ofDóka et al. Sci. Adv. 2016; 2 : e1500968 22 January 2016nicotinamide adenine dinucleotide phosphate), TrxR1 catalytically
reduces HSx
− in a polysulfide concentration–dependent manner
(Fig. 3A). Both the zero-order character of the observed kinetic
traces (reflecting efficient enzyme-catalyzed reactions) and the fact that
substrate saturation could not be achieved using HSx
− concentrations
as high as 1 mM (Fig. 3B) indicated that HSx
− are good substrates for
TrxR1. To test a potential selenopersulfide formation–induced (or
competitive inhibition–mediated) decline in TrxR1 activity in turnover
with selenite as another low–molecular weight substrate of the enzyme
(30), we added 50 mM selenite to the NADPH/TrxR1/polysulfide
mixtures. No enzyme inhibition was detected; rather, an additive
effect was observed in NADPH consumption rates (Fig. 3C and
fig. S2), suggesting that the enzyme is not saturated under these
conditions. These experiments clearly showed that polysulfides are
substrates and not inhibitors of TrxR1.Fig. 2. Detection of protein persulfide formation on HSA. S1 to S4 refer to sampling according to Fig. 1. (A) IAB alkylated HSA-SSH samples are
efficiently pulled down by streptavidin-coated magnetic beads (compare S1 to S2). Lanes S3 and S4 represent HSA-SSH that was reduced off the beads by
TCEP and HSA thiol that was released during boiling, respectively. No bands were detected in S3 when HSA-SSH was reduced by TCEP before alkylation.
Gels are representative of n = 9 experiments. (A′) Incubation of HSA-SSH with 5 mM sulfide for 30 min before alkylation reduces some of the HSA-SSH by
shifting the equilibrium of reaction 1 (see text). (B and B′) HSA-SSH formation was observed in HSx
−-treated plasma samples (B), but no endogenous HSA-SSH
was detectable in untreated plasma (B′) by Colloidal Coomassie Blue staining. Gels are representative of n = 3 experiments. (C and C′ ) Concentration-
dependent (C) HSx
− or (C′ ) H2S treatment induced HSA-SSH formation in plasma detected by immunoblot analyses against HSA. Blots only show S3.
Plasma protein (100 ng) and pure HSA (20 ng) were applied as loading controls. Blots are representative of n = 3 experiments. The observed mobility
shifts on each gels are due to the reduction of structural disulfide bonds in HSA during the final reduction step. Mass spectrometry confirmed that
the shifted bands indeed represent HSA.3 of 14
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 We next assessed whether polysulfide reduction by TrxR1 was Sec-
dependent using mutant variants of the enzyme. A Sec-to-Ser mutant
was inactive (Fig. 3D), whereas a Sec-to-Cys mutant displayed about 5
to 10% turnover (fig. S3A) compared to the wild-type enzyme (Fig. 3A).
Two other mutated variants of truncated TrxR1 lacking the Sec residue
were also inactive (fig. S3, B and C), indicating that polysulfide reduc-
tion by the enzyme was dependent on its proper C-terminal active-site
motif -GCUG and displayed at least 10-fold higher activity in the form
of the native selenoprotein compared to a Sec-to-Cys substituted variant
of the enzyme. These characteristics are typical for most natural TrxR1
substrates (28).
HSx
− reduction rates were further increased upon addition of physio-
logical concentrations of either Trx1 (5 mM) or TRP14 (2 mM) by 1.7-
and 2.6-fold, respectively (Fig. 3E). Furthermore, addition of HSx
− did
not inhibit reduction of the alternative Trx1 substrate insulin (Fig. 3F)
or the TRP14 substrate cystine (Fig. 3G); instead, similar additive effects
were observed as in the selenite assay for TrxR1. These results demonstrated
that the Trx system, comprising NADPH, TrxR1, and Trx1 or TRP14,
provides a potent enzymatic system for the reduction of polysulfides.
Protein persulfide reduction by the Trx system
Next, we investigated whether protein persulfides can be reduced by the
Trx system, first using bovine serum albumin persulfide (BSA-SSH) as a
model substrate. BSA-SSH was produced and detected with ProPerDP
as described for HSA (see fig. S4). TrxR1 alone as well as in a concerted
manner with Trx1 and TRP14 could indeed reduce BSA-SSH. BSA-SSH
was rapidly reduced using 50 nM TrxR1 and either 5 mM Trx1 or 2 mM
TRP14 (Fig. 3H). Control experiments verified that the observed activ-
ities were not due to residual HSx
− (used to generate BSA-SSH) remain-
ing in the protein samples (fig. S5A) and that the catalytic reduction
proceeded in a BSA-SSH concentration–dependent manner (fig. S5, B
and C). With 5 mM Trx1 or 2 mM TRP14 accelerating the BSA-SSH re-
duction rates 1.7- and 2.4-fold, respectively, compared to TrxR1 alone,
the protein persulfide reduction (just like for HSx
−, see above) was
most favorable via the TRP14-catalyzed pathway (Fig. 3H).
Protein persulfide detection in cells
To assess the impact of the Trx system on protein persulfide levels in a
cellular context, we first validated ProPerDP for analyses of protein per-
sulfides in cell lysates. For this, we generated a protein persulfide pool by
treating lysates of A549 human lung carcinoma cells with HSx
−, which
revealed that a number of protein persulfide species could be detected
upon polysulfide treatment that were below detection level in nontreated
samples (Fig. 4A). The protein persulfide species present in the S3
sample again disappeared if the sample was treated with TCEP before
the alkylation step (indicating no background signals even in cell lysates).
To prevent artificial oxidation upon cell lysis, rapid alkylation of reactive
thiol and persulfide groups in intact cells is necessary if protein persul-
fide analyses are to be done with live cells. This is enabled with ProPerDP
because the biotin-tagged alkylating agent (IAB) readily crosses through
cell membranes, demonstrated by the large amounts of proteins removed
by the streptavidin-coated beads when the alkylating agent was used on
intact cells and washed away in the cell culture before the cells were lysed
(Fig. 4B, compare lanes S1 and S2). Most of these proteins could not be
reduced off the beads using TCEP or dithiothreitol (DTT) (Fig. 4B, lane
S4), thus representing proteins with free thiols and other Cys derivatives
that could generate thioether bonds with the alkylating agent inside the
cell (also see Fig. 1). The results shown in Fig. 4B also indicated thatDóka et al. Sci. Adv. 2016; 2 : e1500968 22 January 2016ProPerDP could be used to identify a small subset of proteins that formed
persulfides upon HSx
− treatment in intact cells (Fig. 4B, lane S3). Mass
spectrometry–based identification of some of these proteins (Fig. 4, B
and C, bands 1 to 4) gave closely overlapping results with proteins being
previously reported as persulfidated by Ida et al. (7) and Mustafa et al.
(31). However, considerably lower levels of endogenous protein per-
sulfides were detected compared to those in HSx
−-treated samples. Even
if silver staining was used with highly concentrated samples, the protein
persulfides were only scarcely detectable in the untreated cell sample
(Fig. 4D).
Using ProPerDP, we could also detect protein persulfides in yeast.
Thereby, we were able to test the impacts of the two known sulfide-
generating enzymes (32), which were also proposed to directly generate
persulfide species, cystathionine-b-synthase (CBS) and cystathionine-g-
lyase (CSE) (7), on in vivo levels of protein persulfides. The observed
lower levels of persulfidation in CBS- or CSE-deleted yeast strains com-
pared to the wild-type mother cell line (Fig. 4E) were consistent with the
known activities of these enzymes in generating intracellular H2S, there-
by providing another level of method validation.
Intracellular modulation of protein persulfide homeostasis
by TrxR1 and TRP14
To assess whether the protein persulfide and/or HSx
− reduction by the
Trx system might have an impact on persulfide levels in a cellular con-
text, we constructed stable TrxR1 and TRP14 knockdown human em-
bryonic kidney 293 (HEK293) cell lines (Fig. 5A). Using ProPerDP,
we found that HEK293 cells contained 1.52 ± 0.55 mg of endogenous
basal levels of protein persulfides per milligram of protein, suggesting
that 0.15 ± 0.06% (from n = 3 experiments) of the total proteins are
persulfidated. ProPerDP detected 25 ± 9% and 29 ± 11% (mean ± SD
from n = 4 experiments reaching statistical significance with P < 0.05; see
Fig. 5, B and C) more total persulfidated proteins in the TrxR1- and
TRP14-deficient HEK293 cells, respectively, compared to control cells
[HEK293 cells transfected with a plasmid transcribing a scramble
shRNA (short hairpin RNA)]. Control experiments verified that this
was not due to less efficient alkylation or pulldown by the beads (fig.
S6) and should thereby likely be explained by the lower reduction capac-
ity of persulfide moieties in the cells deficient in TrxR1 or TRP14. In
addition, HSx
− treatment induced more protein persulfide formation
in the deficient cells compared to control cells (Fig. 5D). We estimate
that the level of protein persulfides in the polysulfide-treated control cells
is >3 mg/mg total protein, which is ~2.7- and ~3.7-fold larger in the
TrxR1 and TRP14 knockdown cells, respectively, based on Fig. 5D.
Dose-dependent treatment of intact cells with toxic amounts of HSx
−
for 2 hours resulted in significantly lowered viability of TrxR1-deficient
cells compared to control cells at 24 hours after treatment (Fig. 5E). These
observations collectively show that the Trx system is involved in intra-
cellular reduction of protein persulfide species and in the maintenance
of cellular sulfane sulfur homeostasis.
Polysulfide and protein persulfide reduction
by the GSH system
Working hand in hand with the Trx system, the GSH system serves as
the other major disulfide-reducing machinery in vivo (33). Therefore,
we also investigated its potential to reduce polysulfide and protein per-
sulfide species. Using NADPH and GSH, GR catalyzed the reduction of
HSx
− in a concentration-dependent manner (Fig. 6A). Inclusion of Grx
in the enzyme kinetic assay further increased catalytic power (Fig. 6B).4 of 14
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 Fig. 3. Catalytic reduction of HSx
− and BSA-SSH by the Trx system. (A) Kinetic traces show catalytic reduction of increasing concentrations of HSx
− at
100 nM TrxR1 and 250 mM NADPH following the consumption of NADPH (at 340 nm). (B) Initial rates of NADPH consumption by TrxR1 using HSx
− as substrate
show linear dependence on the HSx
− concentration up to 1 mM. (C) Addition of 50 mM sodium selenite (at the indicated time point by the arrow) to similar reaction
mixtures as in (A) resulted in increased NADPH consumption rates (also see fig. S2). (D) The GCSG mutant of TrxR1 is inactive in a similar activity assay as in (A),
indicating the need for catalysis of the Sec residue (see the activities of further mutants in fig. S3, A to C). (E) TrxR1 concentration–corrected initial rates were increased in
the presence of 5 mM Trx1 and 2 mM TRP14 compared to TrxR1 alone with linear HSx
− concentration dependencies. (F and G) Addition of HSx
− had no inhibitory
potential on TrxR1-coupled (F) insulin-reducing Trx1 activities or (G) cystine-reducing TRP14 activities. (H) Kinetic traces show catalytic reduction of 170 mM
BSA-SSH by 50 nM TrxR1 at 250 mM NADPH, which are further accelerated by 5 mM Trx1 or 2 mM TRP14.Dóka et al. Sci. Adv. 2016; 2 : e1500968 22 January 2016 5 of 14
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 Up to 1 mMHSx
−, linear concentration dependencies were observed for
the catalyzed reduction rates in both assays, suggesting that polysulfides
are good substrates for these enzyme systems (Fig. 6C). Similar to the
Trx system, using BSA-SSH, we found that, in the presence of NADPH,
GR together with GSH has the potential to catalytically reduce protein
persulfide species, with substantially increased reduction rates in the
coupled assay with Grx (Fig. 6D). As above, control experiments verified
that the observed activities were not due to residual HSx
− (which were
used to generate BSA-SSH) remaining in the protein samples (fig. S7).
In vivo orchestration of protein persulfidation by Trx
and GSH systems
To investigate the in vivo significance of the persulfide- and HSx
−-
reducing potentials of the Trx and GSH machineries, we further de-
veloped ProPerDP to detect protein persulfides in tissue samples (see
Materials and Methods for details). Using an analogous protein quan-
tification protocol to the one used for the cellular systems, ProPerDP
measured 11.6 ± 6.9 mg of protein persulfides per milligram of total
protein in the liver of 8- to 10-week-old wild-type male mice (n = 8 dif-
ferent animals). We observed different protein persulfidation patterns
inmouse livers engineered (34) to lack GR (GR-null) or to lack both TrxR1
and GR (TR/GR-null) in hepatocytes as compared to matching wild-typeDóka et al. Sci. Adv. 2016; 2 : e1500968 22 January 2016livers (Fig. 7A). Furthermore, significantly (P = 0.02) elevated persulfide
levels, 20.2 ± 9.0 mg/mg of total protein, were observed in TR/GR-null
liver samples compared to wild type (Fig. 7B). These observations give
credence to the important role of the protein persulfide- and/or HSx
−-
reducing activities of the Trx and GSH systems in governing sulfane
sulfur homeostasis and sulfide signaling in vivo.DISCUSSION
Here, we presented a novel method, ProPerDP, for analysis of protein
persulfide species. We characterized catalytic reduction of such entities
by the Trx system, and we used ProPerDP to show that TrxR1 and TRP14
expression have an impact on protein persulfide accumulation in cells.
TrxR1 knockdown cells were less viable in the presence of toxic amounts
of HSx
−, providing corroborating evidence for the physiological impor-
tance of an intact Trx system to maintain intracellular sulfane sulfur ho-
meostasis. The Grx/GR/GSH system was also found to be capable of
catalytically reducing polysulfide and protein persulfide species. The sig-
nificantly elevated levels of protein persulfides that were detected in TR/
GR-null livers compared to wild-type livers underline the importance of
these reducing systems in protein persulfidation mechanisms in vivo.Fig. 4. Protein persulfide detection in cells. S1 to S4 refer to sampling according to Fig. 1. (A) Detection of persulfides in HSx
−-treated and untreated A549
cell lysates (Coomassie staining). (B) Persulfide detection in HSx
−-treated intact A549 cells, where the alkylating agent is washed away before the cell lysis step, asvisualized by Coomassie staining. The indicated bands in S3 were subsequently subjected to tryptic digestion and mass spectrometry analyses. (C) List of
identified persulfidated proteins from the bands indicated on (B). (D) Endogenous persulfidation can only be visualized by silver staining. Gels are repre-
sentative of n = 3 experiments. (E) More protein persulfides were detected in wild type (WT) compared to cys4D and cys3D yeast strains representing the
corresponding CBS and CSE deleted variants, respectively. For sample preparation and the relevant genotypes, see Materials and Methods.6 of 14
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 Moreover, the different patterns of persulfidated proteins we observed
in wild-type, GR-null, and TR/GR-null livers by gel electrophoresis of
ProPerDP-captured products suggest that there are different specific roles
for the Trx and GSH systems in governing persulfide reduction pathways.
These findings have several implications for the understanding of H2S
signaling through protein persulfide formation and function.
Since the discovery by Snyder’s group that protein persulfidation,
also called sulfhydration, is a major pathway in sulfide signaling (31), a
number of elegant studies have shown that protein Cys persulfide for-
mation can have regulatory functions. Examples include (i) antiapop-
totic transcriptional activity triggered by persulfide-mediated binding
of ribosomal protein S3 (RPS3) to nuclear factor kappa-light-chain-
enhancer of activated B cells (NF-kB) (35), (ii) extracellular signal–
regulated kinases 1/2 (ERK1/2) translocation into the nucleus facilitated
by mitogen-activated protein kinase kinase (MEK1) persulfide formation–
induced poly(ADP-ribose) polymerase 1 (PARP-1) activation leading
to DNA damage repair (36), (iii) adenosine triphosphate (ATP)–sensitiveDóka et al. Sci. Adv. 2016; 2 : e1500968 22 January 2016channel activation upon persulfide-induced inhibition of ATP binding
(37), and (iv) potent inhibition of PTEN (23) or of protein-tyrosine phos-
phatase 1B (PTP1B) (20) activities by persulfidation of their active-site
Cys residues. In addition, a thiol protein–protecting effect by persulfidation
was recently suggested, because persulfide moieties are in theory reducible
oxidative modifications as opposed to irreversible oxidation of Cys thiols
(7, 14, 23). Our results suggest not only that both Trx and GSH systems
participate in the regeneration of such protective modifications but also
that these reducing machineries may thereby be involved in the regulation
of a subset of many key proteins that are regulated by persulfide formation.
Additional studies are required to assess such regulations in a protein-
specific manner, but a general discussion of potential models is already
possible at this stage (see below).
One important question with regard to protein persulfide modifica-
tions as regulatory mechanisms for cell function is how common such
modifications are and at what levels protein persulfides accumulate in
cells. Although a few persulfide assays were published recently, detectionFig. 5. TrxR1 and TRP14 counteract intracellular protein persulfide accumulation. S3 refers to sampling according to Fig. 1. (A) Western blot showing
the knockdown of TRP14 and TrxR1 in stably transfected HEK293 cells, compared to control cells. GAPDH is applied as a loading control. (B) Representative
silver-stained gel (of n = 4 experiments) shows that more protein persulfides are detected in TrxR1 and TRP14 knockdown HEK293 cells than in the control (control
cells have been transfected with a plasmid that transcribes a scramble shRNA) under normal growth conditions. (C) Increases in protein persulfide levels in TrxR1 and
TRP14 knockdown HEK293 cells compared to control reached statistical significance (*P < 0.05 using the paired t test); 100% in the control cells corresponds to 1.52 ±
0.55 mg/mg total protein. Error bars represent SDs of n = 4 experiments. (D) Two hours of treatment with 200 mM polysulfide induced higher levels of intracellular
protein persulfides in intact TrxR1 and TRP14 knockdown cells compared to control cells. (E) A modified SRB cytotoxicity assay revealed that control cells ( • ) are
significantly more viable upon polysulfide exposure than TrxR1 knockdown (○) cells (***P < 0.0001 at 0.5 and 1mMpolysulfide concentration). Data points and error bars
represent the average and SD, respectively, of n = 4 independent experiments of triplicate measurements.7 of 14
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 and quantification of intracellular protein persulfidation have remained
problematic. The most extensively used assays thus far have been the
modified biotin switch (31) and the recently published tag-switch (7, 38)
methods. The modified biotin switch method is based on the assumption
that methyl methanethiosulfonate (MMTS) selectively blocks thiols over
persulfides, which, however, has been questioned a number of times on
chemical grounds (38, 39). In fact, at pH 7, many persulfides were sug-
gested to be even better nucleophiles than the corresponding thiol moi-
eties (14) and would hence be expected to react faster with alkylating
agents (such as MMTS). In the tag-switch assay, methylsulfonyl benzo-
thiazole (MSBT) (the alkylating agent) is not permeable for cell mem-
branes, which excludes the possibility of persulfide detection in intact
live cells. Furthermore, in the “switching” step, methyl cyanoacetate
was suggested to selectively cleave MSBT-labeled dialkyl disulfides (gen-
erated by alkylation of persulfide species) over protein disulfide moieties.
However, selectivity was only assessed on the N-tert-butyloxycarbonyl
derivatized cystine and on glutathionylated bovine serum albumin
(BSA), not taking into account the presence of activated functional dis-
ulfides in cellular systems, which exhibit orders of magnitude larger
reactivities (40). For example, protein disulfide isomerase (PDI) per-
sulfidation could potentially represent a false-positive hit in the tag-
switch assay, because this oxidoreductase uses an activated disulfideDóka et al. Sci. Adv. 2016; 2 : e1500968 22 January 2016moiety in its active site to introduce disulfide bonds in newly synthe-
sized polypeptides in the endoplasmic reticulum (ER) (40). On the oth-
er hand, that reactivity of the PDI disulfide could also potentially be
responsible for its persulfidation by a direct reaction with sulfide in the
ER (25). These examples and uncertainties demonstrate that a new
method to determine intracellular persulfide formation has been high-
ly desired, which was the basis for our development of ProPerDP. It
should be noted that in A549 cells, we identified a limited number of
proteins that were prominently persulfidated upon treatment with HSx
− that all contain a redox-sensitive Cys residue, and most of these pro-
teins were also picked up by the tag-switch or by the modified biotin
switch assays (7, 31). In light of the estimated 20 mM total intracellular
Cys concentration (41, 42) and the fact that most mammalian proteins
have at least one Cys residue (43), the quantified ~0.1 to 1% persulfida-
tion of the total protein pool in cells (1.52 ± 0.55 mg/mg total protein in
HEK293 cells) and liver tissue (11.6 ± 6.9 mg/mg total protein in mice),
respectively, correlates very well with the ~10 to 100 mM small-
molecule persulfide (mostly GSH persulfide) concentrations in A549
cells and mouse liver, respectively, that were measured by Ida et al. (7).
We need to point out that the ProPerDP method is not without
caveats either. Some proteins have more than one surface-exposed thiol
residue, some of which might form persulfides more preferentially thanFig. 6. Catalytic reduction of HSx
− and BSA-SSH by the glutaredoxin system. (A and B) Kinetic traces show catalytic reduction of increasing
concentrations of HSx
− at 6 mg/ml GR, 250 mM NADPH, and 1 mM GSH in the absence (A) or presence (B) of 1 mM Grx1 following the consumption ofNADPH (at 340 nm). (C) Initial rates of NADPH consumption by the GSH system using HSx
− as a substrate in the enzyme systems described in (A) and (B),
represented by “•” and “○” symbols, respectively, show linear dependence on the HSx
− concentration up to 1 mM. (D) Kinetic traces show catalytic
reduction of 170 mM BSA-SSH at 6 mg/ml GR, 250 mM NADPH, and 1 mM GSH in the absence or presence of 1 mM Grx1.8 of 14
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 others. Proteins in which a free thiol is alkylated at the same time as a
persulfide group is present at another site may be lost in our assay
(Fig. 8A). Another caveat with our method is that it could potentially
detect disulfide-linked proteins in which an extra surface-exposed
nonpersulfidated free Cys residue (in the absence of denaturation) also
becomes alkylated (Fig. 8B). However, the fact that the levels of most
of the detected endogenous persulfidated proteins increased in A549
or HEK293 cells (see fig. S8) upon HSx
− treatment suggests that only a
small proportion (if at all) of the observed bands are due to such false-
positive hits. In addition, using two-dimensional (2D) diagonal gel electro-
phoresis (with a nonreducing and a reducing dimension), we could
not detect significant differences in the intermolecular disulfide pools
of the S1 and S2 fractions (fig. S9; see Fig. 1 for an explanation of frac-
tions), corroborating that false-positive hits by ProPerDP via the above
mechanism (Fig. 8B) are likely minor. Furthermore, the fact that reduced
protein persulfide levels were observed in CBS- or CSE-deleted yeast
cells compared to the wild-type mother strain verifies that ProPerDP
indeed detects protein persulfide species. However, it has to be noted that,
in its current form, ProPerDP cannot distinguish between protein per-
sulfides and protein polysulfide species. Therefore, we advise investigators
to be cognizant of the abovementioned limitations when running the
assay. A potential methodological improvement using mass spectrometry–
based detection to overcome the abovementioned caveats (as argued
above, with the false-negative hits being more relevant) is proposed in
Fig. 8C. This includes trypsinization before the affinity purification step,
because on the peptide level, situations outlined in Fig. 8 (A and B) would
become highly unlikely. o
n
 January 25, 2016
.sciencem
ag.org/Fig. 8. Potential caveats of the ProPerDP method. (A) In proteins with more than one free Cys that exhibit different persulfidation properties,
because of a nonpersulfidated Cys residue, the protein can stay immobilized on the streptavidin beads despite containing a persulfide, leading to false-
negative signals. (B) Intermolecular protein disulfide bonds with nonpersulfidated extra Cys residues on one of the polypeptide chains might appear as
false-positive signals in the persulfide proteome. Upon reduction, P2 proteins are cleaved off the beads and could erroneously be present in the persulfide
proteome fractions (Sample 3 in Fig. 1). (C) A potential way to overcome the abovementioned caveats is to digest the alkylated proteins before the
pulldown step because it is highly unlikely that both the free and persulfidated Cys [for (A)] or the disulfide and the free Cys moieties [for (B)] will
end up in the same peptide using this method. With this approach, the alkylated peptide persulfides could be detected by mass spectrometry after
they are cleaved off the beads by the reducing agent. This method improvement is under development in our laboratory.Fig. 7. Trx and GSH systems orchestrate protein persulfide levels in vivo.
(A) Representative silver-stained gel demonstrates the detected differ-
ences in protein persulfide pools of liver samples from mice engineered
to lack GR (GR-null) or TrxR1 and GR (TR/GR-null) in hepatocytes com-
pared to that of an age-matched healthy control (WT). S3 refers to
sampling according to Fig. 1. (B) Increased levels of protein persulfides
were detected by ProPerDP (see Materials and Methods) in GR-null and
TR/GR-null mouse liver samples compared to WT, reaching statistical
significance (*P < 0.05 using nonpaired t test) for TR/GR-null; 100% in
the WT animals corresponds to 11.6 ± 6.9 mg/mg total protein (n = 7
different animals). Error bars represent SDs of n = 8 experiments with
different animals for TR/GR-null and n = 5 for GR-null.9 of 14
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 Possible mechanisms of protein persulfide formation via sulfide or
Cys thiol oxidation processes (5) as well as enzymatic pathways (7, 32)
are being extensively studied. By contrast, counteracting pathways for re-
duction of protein persulfide species are much less well understood. Re-
cent reports from Kimura’s and Tonks’ laboratories have suggested that
3-mercaptopyruvate sulfurtransferase and PTP1B persulfides are likely
to be reduced by Trx1, on the basis of their observed faster reduction
rates compared to DTT, GSH, or dihomo-g-linoleic acid, using purified
enzymes and cell lysate experiments (19, 20). However, to the best of our
knowledge, no mechanistic studies or analyses have been conducted to
date with regard to reduction pathways for either protein persulfides or
polysulfides (HSx
−) in intact cells or tissue samples. Here, we used en-
zyme kinetic studies to demonstrate that TrxR1 catalyzes the direct re-
duction of HSx
− as well as protein persulfide moieties via its Sec residue.
Further catalytic power is introduced in the presence of physiological
concentrations of Trx1 or TRP14. In contrast to most thiol proteins (see
above), the fact that HSx
− did not inhibit the activities of either TrxR1,
Trx1, or TRP14 suggests that any TrxR1 selenopersulfide and Trx1 or
TRP14 persulfide intermediate species (that should form during the re-
duction process; fig. S10) are rapidly reduced by the resolving Cys
residues in the active sites of TrxR1, Trx1, or TRP14.
Perhaps our most important finding with regard to the reduction
of protein persulfides by the Trx system is that TRP14 is an efficient
catalyst. TRP14 is a newly discovered member of the Trx protein family
that lacks activity with typical Trx substrates such as ribonucleotide re-
ductase, insulin, or peroxiredoxins (21). The protein was, however, re-
cently found to support cystine and nitrosothiol reduction (22) and can
also reactivate oxidized PTP1B (44). The latter property of TRP14 be-
comes even more interesting in light of our findings that TRP14 is a pro-
minent protein persulfide reductase, because PTP1B has also been
found to be regulated by persulfidation (20). Hence, TRP14 is emerging
as a very efficient substrate of TrxR1 (22) that may be specifically tailored
for redox signaling purposes. Indeed, particularly under increasingly
oxidizing or proliferating growth conditions, during which Trx would
be heavily engaged in turning over the peroxiredoxin system (45) or
providing electrons for ribonucleotide reductase (46), TRP14 is likely
to be the major regulator of protein persulfide levels because its activity
is not affected by the presence of protein disulfide substrates that are re-
duced by Trx1 but not by TRP14 (22).
Demonstrating the physiological importance of the Trx system for
protein persulfide reduction, the ProPerDP method here allowed us to
measure increased endogenous protein persulfide levels in intact
HEK293 cells upon knockdown of TrxR1 or TRP14. Furthermore, poly-
sulfide treatment induced accumulation of higher protein persulfide levels
in deficient cells, and TrxR1 knockdown cells were significantly more sus-
ceptible to toxic amounts of HSx
− compared to control cells. These observa-
tions highlight that TrxR1 and TRP14 should indeed be considered major
players in the cellular pathways that maintain sulfane sulfur homeostasis.
In addition to roles for the various components of the Trx system
in modulating protein persulfidation, we here report that the GSH system
can also reduce inorganic HSx
− and protein persulfides. This activity is
enzymatically enhanced by inclusion of Grx and represents an independent
mechanism of modulating the cellular persulfide milieu via an NADPH-
dependent reductase system. Although this might represent yet another
physiological process wherein the Trx and GSH systems robustly overlap
with each other, some of our data suggest that the two systems might act
independently to fine-tune the protein persulfide response. Thus, we
found that a distinct subset of proteins are targets for persulfide accumula-Dóka et al. Sci. Adv. 2016; 2 : e1500968 22 January 2016tion in wild-type, GR-null, or TR/GR-null liver samples, suggesting that
the persulfide-reducing capacities of the Trx and GSH systems might be
protein persulfide–specific and potentially involved in different signaling
pathways. Further studies will be required to understand the detailed
molecular mechanisms by which such systems mediate H2S signaling
functions and the respective roles of the Trx and GSH systems in these
processes. The significantly increased and altered levels of protein per-
sulfides observed in the TR/GR-null mouse liver samples emphasize
the orchestrating role of the Trx and GSH systems in reducing protein
Cys persulfides in vivo.
MATERIALS AND METHODS
Reagents
All chemicals were analytical reagent grade or better and purchased from
Sigma-Aldrich, unless indicated otherwise. Sulfide stock solutions were
prepared fresh daily in water using Na2S∙9H2O (ACS reagent, ≥98%).
Sulfide concentrations were determined by two different ultraviolet (UV)–
vis spectrophotometric methods, as described previously (25). Sodium
hypochlorite concentration was determined at 292 nm (e = 350M−1 cm−1).
Polysulfide stock solutions were prepared by dropwise addition of NaOCl
stock solution to sulfide stock solution, at a final concentration ratio of
100 mM HS−/30 mM NaOCl in double-distilled H2O, under vigorous
vortexing conditions to avoid sulfur precipitation, as reported previously
(47). Polysulfide reagent solutions (in which polysulfide/sulfide ratios
were ~3:4 for the preparation of HSA-SSH and ~1:3 for the cell experi-
ments) were prepared by dilution of stock solutions with TE buffer
(100 mM tris-HCl and 2 mM EDTA, pH 7.5). Polysulfide stock solutions
were used within 30 min from preparation.
IAB is a product of Thermo Scientific. Streptavidin-coated magnetic
microparticles were purchased from Sigma or Life Technologies (Dyna-
beads M-280). Streptavidin agarose resin from Thermo Scientific was
used for the detection of BSA persulfide (fig. S4).
Protein expression and purification
Rat TrxR1 was expressed in Escherichia coli BL21 (DE3) gor− strains
cotransformed with pETTRSTER and pSUABC plasmids (48). Four TrxR1
mutants with regard to the C-terminal active site of TrxR1 (-GCUG),
including a Sec-to-Cys or a Sec-to-Ser mutant (-GCCG or -GCSG), a
truncation mutant (-GC), and a combination of truncation and Cys-to-
Ser mutant (-GS), were used in this study and have been described pre-
viously (49). The corresponding plasmids were transformed into the
same E. coli strain, and we used a “2.4/24/24” protocol for all TrxR1
variant protein expression (50, 51). TrxR1 and its mutants were affinity-
purified from 2′5′-ADP Sepharose (GE Healthcare) followed by size-
exclusion chromatography using a Superdex G200 column equipped
on an ÄKTA Explorer 100 workstation (GE Healthcare). Pure TrxR1
proteins were concentrated using a Centriprep Centrifugal Filter Unit
with Ultracel-30 membrane (Millipore), and the concentration was de-
termined by measuring flavin adenine dinucleotide (FAD) absorbance
at 463 nm (e = 11,300 M−1 cm−1); The Bradford method (Bio-Rad) was
also used to make sure that each subunit of the TrxR1 variants contains
one FADmolecule. The specific activity of the enzyme stock solution of the
normal Sec-containing TrxR1 variant used in this study was 9.75 U/mg.
Human Trx1 was expressed in E. coli Stellar strain (Clontech). The
coding region of Trx1 was codon-optimized for protein expression in
E. coli and synthesized (DNA2.0). A His-tag followed by a tobacco etch
virus (TEV) protease recognition site was introduced at the N-terminal10 of 14
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 end of Trx1 for the convenience of purification. The protein was ex-
pressed conventionally and purified using immobilized metal affinity
chromatography (IMAC). The His-tag was removed using TEV protease
(52) and the nontagged Trx1 was eventually separated from the cleavage
reaction mixture by running a counter-IMAC. The purified Trx1 was
stored in TE buffer and concentrated using a Centriprep Centrifugal
Filter Unit with Ultracel-3 membrane (Millipore), with the protein con-
centration determined by calculating from its UV absorbance at 280 nm
(e = 6970 M−1 cm−1). Recombinant TRP14 was expressed and purified
as previously described (22).
Preparation of HSA-SSH and BSA-SSH samples
Reduction of Cys residues on single-protein or complex biological samples
(1 to 10 mg/ml protein), where indicated, was achieved by incubation
with 1 mMTCEP in 100 mM tris-HCl/2 mMEDTA buffer at pH 7.5 (TE)
for 30 min (prereduction step). TCEP was removed from the samples
by Zeba Desalting Spin Columns (0.5 ml, 7K MWCO). Persulfide for-
mation was induced by the addition of 10 mMHS−/3 mMNaOCl to the
samples [incubation in the dark at room temperature (RT) for 30 min].
Residual polysulfides were removed by gel filtration using Zeba Desalting
Spin Columns (0.5 ml, 7K MWCO).
Treatment of human plasma samples
by sulfide or polysulfides
Peripheral venous blood was obtained from healthy adult humans
with informed consent. The procedure was approved by the Hungarian
National Ethics Committee under file number BPR-021/00084-2/2014.
Blood samples were collected into EDTA collection tubes and centri-
fuged at 3000 rpm for 10 min. The supernatant plasma was aliquoted
into equal volumes, and protein content was determined by the
Bradford assay (Bio-Rad). The total protein concentration of plasma
samples fell into the 89.6 ± 11.6 mg/ml range. Samples were diluted to
10 mg/ml and treated with the indicated amount (for Fig. 2, C and C′)
or with 3 mM polysulfide reagent or buffer (for Fig. 2, B and B′) in the
dark at RT for 30 min, desalted by Zeba 7K MWCO Desalting Spin
Columns (Thermo Scientific), and then alkylated by 1 mM IAB for
1 hour (Fig. 2, C and C′). After the alkylation, the ProPerDP method
was applied to the plasma samples.
The ProPerDP method for purified protein samples
Desalted protein solutions were split into two aliquots of equal volume
and incubated with or without 5 mM TCEP for 30 min at RT followed
by alkylation with 1 mM IAB (3 hours at RT). The excess IAB was re-
moved by gel filtration and by ultrafiltration using Amicon microcon-
centrators (Merck) or by dialysis overnight against TE buffer (using
Pur-A-Lyzer Mini 12000 Dialysis Kit, Sigma). Biotinylated proteins
were pulled down by streptavidin-coated magnetic beads (Sigma). After
a 30-min incubation step on a shaking table, magnetic beads were separated
from the solution phase with amagnetic particle separator (DynalMPC-M).
The supernatant was placed in a clean tube, and the beads were washed
three times with tris-buffered saline containing 0.05% Tween 20
(TBST) to eliminate nonspecific adhesion. The beads were then resus-
pended and incubated with 5 mM TCEP (30 min, gentle mixing). The
magnetic separation was repeated and the beads were finally boiled at
100°C for 3 min in SDS-PAGE sample loading to elute all bound
material. The samples were then analyzed by SDS-PAGE gel electro-
phoresis or Western blot analyses and/or mass spectrometry depend-
ing on the composition and concentration conditions of the originalDóka et al. Sci. Adv. 2016; 2 : e1500968 22 January 2016sample. Protein concentrations were monitored throughout the process
by the Bradford assay using the Bio-Rad protein reagent.
Protein persulfide detection in intact cells by ProPerDP
A549 or HEK293 cells were incubated in the presence or absence of 200 mM
polysulfide in Hanks’ balanced salt solution (HBSS; Lonza) for 30 min
or 2 hours (in Fig. 5D) at 37°C, after which cells were rinsed with
phosphate-buffered saline (PBS) or HBSS and incubated with 1 mM
IAB (Thermo Scientific) in HBSS for 3 hours at 37°C. The cells were then
washed two times with PBS or HBSS and lysed by scraping them in lysis
buffer [40 mM Hepes, 50 mM NaCl, 1 mM EGTA, 1 mM EDTA (pH
7.4), and 1% CHAPS] containing 1% protease inhibitor cocktail
(Sigma). Insoluble material was removed by centrifugation at 14,500 rpm
for 5 min. Protein concentration was determined using the Bradford
assay. Biotinylated proteins were pulled down by streptavidin-coated mag-
netic beads (Sigma), and from this step, the same protocol was applied
as for the purified protein samples, using 25 mMDTT instead of 5 mM
TCEP to cleave the persulfidated proteins off the beads.
Protein persulfide detection in yeast strains by ProPerDP
To prepare protein extracts, cells in log phase were washed, resuspended
in PBS + 1.2 M sorbitol, and digested with Zymolyase 100T (0.5 mg/ml;
MP Biomedicals) at RT for 60 min. Yeast spheroplasts were washed and
resuspended in PBS + 1.2 M sorbitol containing 5 mM of IAB and in-
cubated at RT for 60 min. Spheroplasts were washed and resuspended
in 500 ml of ice-cold lysis buffer [PBS 1×, 0.1% Triton X-100, containing
protease inhibitor mix (complete, EDTA-free, Roche)]. Glass beads (Sigma)
were added and cells were lysed by vigorous vortexing for 1 min at 4°C.
Lysates were clarified by centrifugation at 14,000g at 4°C for 10 min and
the ProPerDP method was then applied on the extracts.
Protein persulfide detection in frozen tissue samples
by ProPerDP
Frozen tissue samples were dropped into liquid nitrogen immediately
after taking them out from −80°C. A fine powder was made from these
snap-frozen tissue samples in a liquid nitrogen–precooled Teflon/iridium
ball Mikro Dismembrator 2 ball-mill (B. Braun Melsungen AG). IAB
solution (3 mM) was added to this fine powder, and the mixture was
incubated for 1 hour at RT. Following the addition of 1% CHAPS and
a protease inhibitor cocktail, the mixture was incubated for an additional
30 min. Tissue debris was separated by 10-min centrifugation at 14,000g,
and the protein content was determined in the supernatant by the Brad-
ford method to set the protein levels to 1 mg/ml (these samples repre-
sented S1 on Fig. 1). From here, the detection method was the same as
that with the A549 and HEK293 cells.
Estimation of endogenous protein persulfide levels
Protein persulfide levels in intact HEK293 cells and mouse liver tissue
samples were estimated by densitometric analysis of the corresponding
silver-stained gels using the ImageJ [National Institutes of Health
(NIH)] or Quantity One (Bio-Rad) software. For the control cells or
animal tissue samples, the optical density of the S3 fractions (representing
the persulfide pool) was compared to an appropriate dilution of the
cell or tissue lysates with measured total protein content ran on the same
gel (n = 3 to 8 experiments). In the case of the knockdown cell lines, the
relative increase in persulfide levels was calculated by comparison of the
S3 samples with the corresponding control cells. Statistical significance
was probed by paired t test on HEK293 cells and nonpaired t test on11 of 14
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 tissue samples. All tests were two-sided, and a P value less than 0.05 was
considered statistically significant.
SDS-PAGE gel electrophoresis
Samples were run on nonreducing 12% polyacrylamide gels. Equal amounts
of total protein were incubated with the streptavidin-coated beads in
the case of each given gel and blot, as judged by the Bradford protein
assay. The total protein loadings in S1 lanes are as follows: 5 mg in Fig. 2
(A and A′), 15 mg in Fig. 2 (B and B′), 10 mg in Fig. 4A, 12 mg in Fig. 4B,
15 mg in Fig. 4D, 5 mg in fig. S1, and 10 mg in fig. S4. In the case of Fig. 2
(C and C′), S3 lanes represent the HSA persulfide fractions of 90 ng of
total plasma protein. Total untreated plasma protein (100 ng) and un-
treated HSA (20 ng) were applied as loading controls. Similarly, only S3
lanes are shown in Fig. 5 (B and D); the corresponding S1 lanes con-
tained 28 and 26 mg of protein, respectively (see fig. S6). Gels were vi-
sualized with colloidal Coomassie staining solution or via silver staining.
Diagonal gel electrophoresis
2D diagonal gel electrophoresis was carried out as described previously
(53). Briefly, S1 and S2 fractions (see Fig. 1 for explanation of fractions)
from A549 and HEK293 cell samples were run in 12% polyacrylamide
gels, first in a nonreducing dimension and then in a reducing dimension
and the obtained gels were silver-stained. The spots located in the upper
half of the gels (above the diagonal) correspond to proteins containing
intramolecular disulfide bonds, whereas proteins intermolecularly
linked by disulfide bonds are found below the diagonal.
Western blotting against HSA
Following SDS-PAGE gel electrophoresis, plasma samples were trans-
ferred to polyvinylidene difluoride membranes and blocked overnight
in 3% BSA solution at 4°C. Membranes were then incubated for 1 hour
in anti-albumin antibody (Sigma A0433), diluted 1:10,000 in 3% BSA.
Subsequently, the membranes were washed three times with TBST
buffer and incubated for 1 hour in alkaline phosphatase–conjugated sec-
ondary antibody (Sigma A3687), diluted 1:10,000 in 3% BSA. Mem-
branes were washed again three times in TBST buffer, and the bands
were visualized by 5-bromo-4-chloro-3-indolyl phosphate–nitro blue
tetrazolium (Merck).
Enzyme kinetic studies
All kinetic experiments were carried out in TE buffer (50 mM tris-HCl
and 2 mM EDTA, pH 7.5) at RT, in 96-well microtiter plates. NADPH
consumption was followed at 340 nm, the absorption maximum of re-
duced NADPH. In a typical kinetic experiment, the calculated amount
of polysulfide or persulfide sample was pipetted in the plate and the assay
was started by the addition of a Master Mixture, containing the appro-
priate amount of NADPH, TrxR1, Trx1, or TPR14, or alternatively,
NADPH, GSH, GR, and Grx1 as indicated. Initial rates from each run
were calculated from the slopes of the linear ranges of the curves. Turn-
over was calculated using an NADPH standard curve and dividing the
initial rate with the concentration of TrxR1 (Fig. 3).
A549 cell cultures
The A549 human lung carcinoma cell line was obtained from the European
Collection of Cell Cultures (ECACC 12H017) (Sigma) and cultured in
DMEM (Dulbecco’s modified Eagle’s medium)–F12 medium (Lonza)
supplemented with 10% (v/v) heat-inactivated fetal bovine serum (FBS),
penicillin (100 U/ml), and streptomycin (100 mg/ml) (Sigma) at 37°C in aDóka et al. Sci. Adv. 2016; 2 : e1500968 22 January 2016humidified atmosphere of 5% CO2. A549 cells were free of mycoplasma con-
tamination tested by theMycoSensor QPCRAssay Kit (Agilent Technologies).
Generation of stably transfected HEK293 cells
HEK293 cells were from the American Type Culture Collection (ATCC)
and were cultured in Eagle’s minimum essential medium (ATCC),
complemented with 10% (v/v) FBS (PAA Laboratories), penicillin,
(100 U/ml), and streptomycin (100 mg/ml) (Biochrom AG). Cells were
kept in logarithmic growth phase at 37°C in humidified air containing
5% CO2. Knockdown of TRP14 and TrxR1 was performed using
shRNA-bearing plasmids [from Qiagen, KH19389H (human TXNDC17,
encoding TRP14) and KH02104H (human TXNRD1)] for the respective
proteins as described earlier (22). A negative control shRNA plasmid was
included as a control. For stable knockdown, HEK293 cells were seeded
in six-well plates at a density of 4 × 105 cells per well 24 hours before
transfection. All plasmids were transfected using TurboFect (Thermo
Scientific) as transfection reagent with 0.6 mg DNA and 1.2 ml TurboFect
per well. Transfected cells were selected by adding Hygromycin B
(0.1 mg/ml; Invitrogen) to the growth medium 72 hours after trans-
fection. After approximately 3 weeks, separate populations of stably
transfected cells were generated by selecting single resistant cell clones.
Selection was continued until enough cells were available for genera-
tion of freezing stocks. The knockdown was verified in all clones by
Western blot using antibodies against TrxR1 (sc-58444) and TRP14
(R&D Systems MAB3504), and GAPDH was used as a loading control
(sc-25778). Upon validation, Hygromycin B was removed from the
growth medium, which did not affect the knockdown of the proteins
over several passages. HEK293 cells were free of mycoplasma contamina-
tion tested by the MycoSensor QPCR Assay Kit (Agilent Technologies).
Yeast strains
Yeast strains used in this work were derived from BY4742 (54) and are
described in Table 1. Saccharomyces cerevisiae cells were grown at 30°C
in Synthetic Complete medium (6.7 g of yeast nitrogen bases without
amino acids, 1.89 g/liter of drop-out mix containing all the amino
acids and supplements, and 20 g/liter of dextrose).
Sulforhodamine B assay for cytotoxicity screening
Sulforhodamine B (SRB) assay was performed as described by Vichai et al.
(55). HEK293 (control and TrxR1 knockdown) cells (5 × 103) were
seeded to 96-well cell culture plates per well and incubated for 24 hours
at 37°C in 5% CO2 atmosphere. After 24 hours, 0.2 to 3 mM HSx
− was
added in HBSS and cells were incubated for 2 hours. After the expo-
sure period with polysulfide, HBSS was replaced by complete cell growth
medium and SRB assay was performed after 24 hours. Before fixation,
cells were rinsed with HBSS. Cells were fixed by adding 100 ml of 10%
ice-cold trichloroacetic acid to each well, incubated at 4°C for 1 hour,
and then washed with distilled water. Fifty microliters of SRB stain (0.4%Table 1. Yeast strains used in the present study.Strain Relevant genotype SourceBY4742 (WT) MATa his3D1 leu2D lys2D ura3D (54)cys3D (CSE deleted) BY4742 cys3::KanMX4 (59)cys4D (CBS deleted) BY4742 cys4::KanMX4 (59)12 of 14
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 in 1% acetic acid) was added to each well and incubated for 15 min at
RT. The plates were rinsed four times with 1% acetic acid and 200 ml of
10 mM tris base solution (pH 10.5) was added to each well, and the plates
were shaken for 5 min to solubilize the protein-bound dye. Absorbance
was read on a plate reader (BioTek) at 570 nm. Cell survival was measured
as absorbance (optical density) of the mean of the 12 replicate wells com-
pared to the control (no polysulfide-treated wells). Paired t test was per-
formed using the GraphPad Prism Software.
There was a slight difference in the proliferation of the untreated wild-
type and TrxR1 knockout cells after 24 hours. Control cells had about
12% higher proliferation rate; however, this was statistically not signif-
icant (t test, P = 0.14). Nonetheless, to correct for this difference, results
obtained from the SRB assay are presented as
% of control cell growth
¼ mean OD sample 24 hours − mean OD sample 2 hours
mean OD neg control 24 hours − mean OD neg control 2 hours
100
Hence, in all cases, dose-response data upon polysulfide treatment
were corrected with the untreated control cell growth, so that differences
to untreated cell proliferation were taken into account.
Mass spectrometry analysis
After destaining of QC Colloidal Coomassie Blue (Bio-Rad)–stained
SDS-PAGE gels with H2O:CH3OH:CH3COOH (5:4:1), the indicated
bands were cut out, reduced with DTT, alkylated with iodoacetamide,
and then digested with trypsin from porcine pancreas (dimethylated,
proteomics grade, Sigma) as suggested by the UCSF (University of
California, San Francisco) Mass Spectrometry Core Facility (56, 57).
Before liquid chromatography–mass spectrometry measurements, the
digested samples were cleaned with C18 ZipTip pipette tips (Millipore).
Tryptic peptides were separated by reversed-phase chromatography with
a nanoflow high-performance liquid chromatography (HPLC) (Easy nLC
II, Thermo Fisher Scientific) system on an EASY-column (10 cm, 75 mm,
C18) using gradient elution [developed from 5% (v/v) acetonitrile,
0.1% (v/v) formic acid to 90% (v/v) acetonitrile, 0.1% (v/v) formic acid
in water over 40 min at a flow rate of 300 nl/min]. The nanoflow HPLC
system was coupled to an LTQ XL ion trap mass spectrometer (Thermo
Fisher Scientific) for peptide analyses that was conducted in triple play
positive ion mode in a mass range between 400 and 1500 m/z (mass/
charge ratio). All tandem mass spectrometry samples were analyzed
using ProteinProspector (UCSF Mass Spectrometry Facility, v 5.14.1).
Data were searched against NCBI (National Center for Biotechnology
Information) no. 2013.06.17 database with Homo sapiens as taxonomy.
One missed cleavage was allowed.
Preparation of mouse liver tissue samples
Mouse care and use were performed at Montana State University (MSU)
following guidelines set forth by the U.S. NIH and outlined in the current
Guide for the Care and Use of Laboratory Animals (58). Animal protocols
were approved by theMSU Institutional Animal Care and Use Committee.
The alleles, allelic combinations, and detailed care conditions have
been described previously (34). Eight- to 10-week-old males of the in-
dicated genotypes were euthanized, and livers were perfused by a cardiac-
to-portal route with a solution of 150 mMNaCl, 100 mMPipes (pH 7.1),
and 3.0 mM IAB. Perfused livers were removed and divided into
~100-mg pieces, and each was submerged in a 1.5-ml tube containingDóka et al. Sci. Adv. 2016; 2 : e1500968 22 January 2016perfusion buffer. Samples were incubated on ice for 15 to 20 min, ex-
cess perfusion buffer was removed, tubes were sealed, and the samples
were snap-frozen in liquid nitrogen. Samples were kept at −80°C or on
dry ice until use.SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/2/1/e1500968/DC1
Fig. S1. HSA persulfide is reduced to HSA by sulfide in a dose-dependent manner.
Fig. S2. Selenite-reducing TrxR1 activity is not inhibited by polysulfides.
Fig. S3. Compromised polysulfide reduction by TrxR1 mutants lacking the Sec residue.
Fig. S4. Detection of persulfide formation on BSA.
Fig. S5. BSA-SSH reduction by NADPH/TrxR1-coupled Trx1 and TRP14.
Fig. S6. Relative efficiency of alkylation and streptavidin pulldown in the ProPerDP method
applied to control and TrxR1 or TRP14 knockdown HEK293 cells.
Fig. S7. Control experiment to the BSA-SSH reduction by the NADPH/GR/GSH-coupled Grx1
experiment (see Fig. 6 in the main text).
Fig. S8. Endogenously detected protein persulfides exhibit elevated levels in HSx
−-treated
TrxR1, TRP14 knockdown, or control HEK293 cells.
Fig. S9. Diagonal gel electrophoresis experiment corroborates that false-positive hits outlined
in Fig. 8B by ProPerDP are of minor importance.
Fig. S10. Suggested scheme for polysulfide reduction by the NADPH/TrxR1-coupled TRP14 system.REFERENCES AND NOTES
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